Individual and combined glucose-lowering effects of glucagon receptor antagonism and dipeptidyl peptidase-4 inhibition

被引：0
|
作者：
Maagensen, H. [1 ]
Haedersdal, S. [1 ]
Lund, A. [1 ]
Nielsen-Hannerup, E. [1 ]
Holst, J. [2 ]
Knop, F. [1 ,2 ]
Vilsboll, T. [3 ,4 ]
机构：
[1] Steno Diabet Ctr Copenhagen, Clin Metab Physiol, Hellerup, Denmark
[2] Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark
[3] Steno Diabet Ctr Copenhagen, Gentofte, Denmark
[4] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark
来源：
DIABETOLOGIA | 2018年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
504
引用
收藏
页码：S246 / S247
页数：2
相关论文
共 50 条
  • [21] Factors Related to the Glucose-Lowering Efficacy of Dipeptidyl Peptidase-4 Inhibitors: A Systematic Review and Meta-Analysis Focusing on Ethnicity and Study Regions
    Kayo Fujita
    Masayuki Kaneko
    Mamoru Narukawa
    Clinical Drug Investigation, 2017, 37 : 219 - 232
  • [22] Differences in the glucose-lowering efficacy of dipeptidyl peptidase-4 inhibitors between Asians and non-Asians: a systematic review and meta-analysis
    Y. G. Kim
    S. Hahn
    T. J. Oh
    S. H. Kwak
    K. S. Park
    Y. M. Cho
    Diabetologia, 2013, 56 : 696 - 708
  • [23] Nonglycemic effects of dipeptidyl peptidase-4 inhibitors
    Ametov, A. S.
    Kamynina, L. L.
    TERAPEVTICHESKII ARKHIV, 2013, 85 (01) : 98 - 102
  • [24] Effects of dipeptidyl peptidase-4 inhibition in vivo: Dipeptidyl peptidase-4 inhibitor/gut microbiome crosstalk suggests novel therapeutic options for diabetes management
    Yasuda, Takuma
    Harada, Norio
    Inagaki, Nobuya
    JOURNAL OF DIABETES INVESTIGATION, 2024, 15 (06) : 704 - 706
  • [25] Increasing Age Associated with Higher Dipeptidyl Peptidase-4 Inhibition Rate Is a Predictive Factor for Efficacy of Dipeptidyl Peptidase-4 Inhibitors
    Hong, Sangmo
    Jung, Chang Hee
    Han, Song
    Park, Cheol-Young
    DIABETES & METABOLISM JOURNAL, 2022, 46 (01) : 63 - +
  • [26] The role of renal dipeptidyl peptidase-4 in kidney disease: renal effects of dipeptidyl peptidase-4 inhibitors with a focus on linagliptin
    Kanasaki, Keizo
    CLINICAL SCIENCE, 2018, 132 (04) : 489 - 507
  • [27] Effects of dipeptidyl peptidase-4 inhibition on gastrointestinal function, meal appearance, and glucose metabolism in type 2 diabetes
    Vella, Adrian
    Bock, Gerlies
    Giesler, Paula D.
    Burton, Duane B.
    Serra, Denise B.
    Saylan, Monica Ligueros
    Dunning, Beth E.
    Foley, James E.
    Rizza, Robert A.
    Camilleri, Michael
    DIABETES, 2007, 56 (05) : 1475 - 1480
  • [28] Dipeptidyl Peptidase-4 Inhibition Improves Diabetic Wound Healing
    Long, Min
    Zheng, Hongting
    Cai, Leiqin
    Zhang, Linlin
    Li, Wenjie
    Zhang, Rui
    Zheng, Yi
    Li, Xing
    DIABETES, 2017, 66 : LB13 - LB13
  • [29] Inhibitor selectivity in the clinical application of dipeptidyl peptidase-4 inhibition
    Kirby, Mark
    Yu, Denise M. T.
    O'Connor, Stephen P.
    Gorrell, Mark D.
    CLINICAL SCIENCE, 2010, 118 (1-2) : 31 - 41
  • [30] The effects of dipeptidyl peptidase-4 inhibitors on kidney outcomes
    O'Hara, Daniel V.
    Parkhill, Thomas R.
    Badve, Sunil V.
    Jun, Min
    Jardine, Meg J.
    Perkovic, Vlado
    DIABETES OBESITY & METABOLISM, 2021, 23 (03): : 763 - 773
12345